Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Epredia™ Lab Vision™ MUC-1 Mouse Monoclonal Antibody, 200μg/mL with BSA and azide
Deliver accurate, reproducible results with the Epredia™ MUC-1, Mouse Monoclonal Antibody.
Specifications
| Antigen | MUC-1 |
|---|---|
| Clone | SPM492 |
| Applications | Immunohistochemistry (Paraffin) |
| Classification | Monoclonal |
| Conjugate | Unconjugated |
| Catalog Number | Mfr. No. | Form | Quantity | Price | Quantity & Availability | ||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number | Mfr. No. | Form | Quantity | Price | Quantity & Availability | ||||
|
MS10340P0
|
Epredia™
MS10340P0 |
Concentrated | 100 μL | N/A | N/A | N/A | |||
|
MS10340P1
|
Epredia™
MS10340P1 |
Concentrated | 500 μL | N/A | N/A | N/A | |||
|
MS10340P
|
Epredia™
MS10340P |
Concentrated | 1 mL | N/A | N/A | N/A | |||
|
MS10340R1
|
Epredia™
MS10340R1 |
Prediluted | 1 mL | N/A | N/A | N/A | |||
|
MS10340R7
|
Epredia™
MS10340R7 |
Prediluted | 7 mL | N/A | N/A | N/A | |||
Description
MUC-1 is a heavily O-glycosylated transmembrane protein expressed on most secretory epithelium, including mammary gland and some hematopoietic cells. It is expressed abundantly in lactating mammary glands and overexpressed abundantly in >90% breast carcinomas and metastases. Transgenic MUC-1 has been shown to associate with all four cebB receptors and localize with erbB1 (EGFR) in lactating glands.Host Species: Mouse
Clone: SPM492
Isotype: IgG1/k
Species Reactivity: Human. Others not tested.
Epitope: Not known
Immunogen: Human breast cell line ZR-75-1
Molecular Weight: 265-400kDa
Positive Control: Breast CA
Recommended for:
- Immunohistochemistry (Formalin/paraffin)
Note:
USA: RUO; Int'l: RUO
Specifications
| MUC-1 | |
| Immunohistochemistry (Paraffin) | |
| Unconjugated | |
| RUO | |
| Human | |
| IgG2a κ |
| SPM492 | |
| Monoclonal | |
| Mouse | |
| Cancer and Tumor Biology | |
| Human breast cell line ZR-75-1 | |
| Primary |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title